Improving enrollment in clinical trials for blood cancers
Official title: Addressing Underperformance in Clinical Trial Enrollments: Development of a Clinical Trial Toolkit and Expansion of the Clinical Research Footprint
Funded at Johns Hopkins University · NIH-10931341 · Data updated 2026-11-12
This study is working to make it easier for people with blood cancers to join clinical trials, especially during COVID-19, by creating helpful tools and offering more local options for participation.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Johns Hopkins University NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project start | September 19, 2023 |
| Project end | August 31, 2028 |
| Funding year | 2024 |
| Award (this year) | $160,532 |
| NIH project number | 5R50CA278859-02 |
| Project ID | NIH-10931341 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are patients diagnosed with hematologic malignancies who are seeking treatment options and may benefit from participation in clinical trials.
✕Less likely to help
Patients with non-hematologic cancers or those not interested in clinical trial participation may not receive benefits from this research.
What this research studies
This research aims to enhance the enrollment of patients in clinical trials focused on hematologic malignancies, particularly in the context of challenges posed by COVID-19. It employs a two-pronged approach that addresses both systemic and patient-related barriers to participation. A clinical trial toolkit will be developed to streamline operations, improve trial feasibility, and prioritize studies that best serve patient needs. Additionally, the research seeks to extend clinical trial opportunities to satellite sites, making participation more accessible for patients who prefer local care.
Why it matters
Potential benefit: If successful, this research could lead to increased participation in clinical trials, providing patients with access to innovative treatments and improving outcomes in blood cancer care.
How similar studies have gone: Previous research has shown that addressing barriers to clinical trial enrollment can significantly improve participation rates, indicating that this approach has potential for success.
Where this research is happening
-
Johns Hopkins University
Baltimore, United States Active
Researchers
- Principal investigator: Wagner-Johnston, Nina Delaney — Johns Hopkins University
- Study coordinator: Wagner-Johnston, Nina Delaney
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.